Estrella Immunopharma, Inc.

Estrella Immunopharma, Inc.

ESLAW
Estrella Immunopharma, Inc.US flagNASDAQ Capital Market
0.13
USD
-0.01
- -
40.36MMarket Cap

Income Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
06/30/2021
06/30/2022
06/30/2023
06/30/2024
12/31/2025
Sales/Revenue/Turnover
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
- Operating Expenses
1
2
11
7
13
+ Selling, General & Admin
- -
- -
1
3
3
+ Research & Development
- -
1
10
4
10
+ Other Operating Expense
- -
- -
- -
- -
- -
Operating Income (Loss)
-1
-2
-11
-7
-13
- Non-Operating (Income) Loss
- -
- -
- -
- -
- -
+ Interest Expense, Net
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
Pretax Income
-1
-2
-11
-7
-13
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
-1
-2
-11
-7
-13
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
-1
-2
-11
-7
-13
- Minority Interest
- -
- -
- -
- -
- -
Net Income, GAAP
-1
-2
-11
-7
-13
- Preferred Dividends
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
-1
-2
-11
-7
-13
EBIT
-1
-2
-11
-7
-13
EBITDA
-1
-2
-11
-7
-13
EBITDA Margin (%)
- -
- -
- -
- -
- -
EBITA
-1
-2
-11
-7
-13
Gross Margin (%)
- -
- -
- -
- -
- -
Operating Margin (%)
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
Basic EPS from Cont Ops
- -
- -
- -
- -
- -
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
Diluted EPS, GAAP
- -
- -
- -
- -
- -
Diluted EPS from Cont Ops
- -
- -
- -
- -
- -

Balance Sheet (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
06/30/2021
06/30/2022
06/30/2023
06/30/2024
12/31/2025
Total Current Assets
- -
5
3
4
2
+ Cash, Cash Equivalents & STI
- -
4
2
4
1
+ Cash & Cash Equivalents
- -
4
2
4
1
+ ST Investments
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
+ Inventories
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
- -
- -
- -
+ Misc ST Assets
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
Total Noncurrent Assets
- -
- -
- -
- -
2
+ Property, Plant & Equip, Net
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
- -
- -
- -
- -
+ LT Investments
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
+ Other LT Assets
- -
- -
- -
- -
2
+ Total Intangible Assets
- -
- -
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
+ Misc LT Assets
- -
- -
- -
- -
2
Total Assets
- -
5
3
4
3
+ Payables & Accruals
- -
1
10
- -
13
+ Accounts Payable
- -
1
9
- -
1
+ Accrued Taxes
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
- -
- -
- -
13
+ ST Debt
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
Total Current Liabilities
- -
1
10
- -
14
+ LT Debt
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
+ Other LT Liabilities
- -
5
5
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
+ Misc LT Liabilities
- -
5
5
- -
- -
Total Noncurrent Liabilities
- -
5
5
- -
- -
Total Liabilities
- -
6
15
- -
14
+ Preferred Equity and Hybrid Capital
- -
5
5
- -
- -
+ Share Capital & APIC
- -
- -
- -
24
27
+ Common Stock
- -
- -
- -
- -
- -
+ Additional Paid in Capital
- -
- -
- -
24
27
- Treasury Stock
- -
- -
- -
- -
1
+ Retained Earnings
- -
-1
-12
-20
-37
+ Other Equity
- -
- -
- -
- -
- -
Equity Before Minority Interest
- -
-1
-12
4
-10
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
Total Equity
- -
-1
-12
4
-10
Total Liabilities & Equity
- -
5
3
4
3
Shares Outstanding
35
35
35
36
38
Number of Employees
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
Net Debt
- -
-4
-2
-4
-1
Net Debt to Equity
- -
393.17
21.11
-97.47
13.35
Tangible Common Equity Ratio
- -
-122.72
-552.85
95.94
-326.29
Current Ratio
- -
5.2
0.28
24.65
0.12
Cash Conversion Cycle
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChatGPT
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
As of date
06/30/2021
06/30/2022
06/30/2023
06/30/2024
12/31/2025
+ Net Income
-1
-2
-11
-7
-13
+ Depreciation & Amortization
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
- -
- -
1
1
+ Stock-Based Compensation
- -
- -
- -
1
1
+ Deferred Income Taxes
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
- -
- -
+ Chg in Non-Cash Work Cap
- -
- -
9
-10
11
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
1
- -
- -
+ Inc (Dec) in Accts Payable
- -
1
9
-10
10
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Operating Activities
-1
-1
-1
-16
-2
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
- -
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
+ Cash (Repurchase) of Equity
- -
- -
- -
- -
2
+ Increase in Capital Stock
- -
- -
- -
- -
2
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
5
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
- -
- -
5
- -
+ Dividends Paid
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
+ Cash From Debt
- -
- -
- -
1
- -
+ Repayments of Debt
- -
- -
- -
-1
- -
+ Other Financing Activities
1
6
- -
13
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
Cash from Financing Activities
1
6
- -
13
2
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
Net Changes in Cash
- -
4
-2
2
- -
EBITDA
-1
-2
-11
-7
-13
EBITDA Margin (%)
- -
- -
- -
- -
- -
Free Cash Flow
-1
-1
-1
-16
-2
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
4
-1
-21
-2
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
Price/Free Cash Flow
- -
- -
- -
- -
- -
Cash Flow to Net Income
0.91
0.86
0.12
2.2
0.14
Capital Expenditures
- -
- -
- -
- -
- -